Evidence map›Paper›PMID 23583373›Full record

ArticleBiochemical and biophysical research communications2013

Early VEGFR2 activation in response to flow is VEGF-dependent and mediated by MMP activity.

Nathaniel G dela Paz, Benoît Melchior, John A Frangos

Open access · greenAbstract read
In one paragraph

Article in Biochemical and biophysical research communications, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 22 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Biophysics of Cell-Substrate Interactions Under Shear.Frontiers in cell and developmental biology · 2019
    Review
  9. Article
  10. Mechanisms and regulation of endothelial VEGF receptor signalling.Nature reviews. Molecular cell biology · 2016
    Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Nathaniel G dela PazLa Jolla Bioengineering Institute, 3535 General Atomics Court, Suite 210, San Diego, CA 92121, USA. ndelapaz@ljbi.org
Benoît Melchior
John A Frangos
La Jolla Bioengineering Institute · US

Funding

Shear Stress Activation of Endothelial Membrane FunctionR37HL040696 · NHLBI · LA JOLLA BIOENGINEERING INSTITUTE · PI FRANGOS, JOHN A · 2009 to 2018
$5.8M
NHLBI NIH HHS 3R37HL040696-26S1NHLBI NIH HHS 5R37HL040696-26NHLBI NIH HHS R37 HL040696
6 · The paper itself

Abstract

Although several potential mechanosensors/mechanotransducers have been proposed, the precise mechanisms by which ECs sense and respond to mechanical forces and translate them into biochemical signals remains unclear. Here, we report that two major ligand-dependent tyrosine autophosphorylation sites of VEGFR2, Y1175 and Y1214, are rapidly activated by shear stress in human coronary artery endothelial cells (HCAECs). Neutralizing antibody against VEGFR2 not only abrogates flow-induced phosphorylation of these tyrosine residues, but also has a marked inhibitory effect on downstream eNOS activation. In situ proximity ligation assay revealed that VEGF and VEGFR2 are closely associated in HCAECs, and more importantly, this association is increased with flow. Finally, we show that flow-induced VEGFR2 activation is attenuated in the presence of the broad spectrum matrix metalloproteinase (MMP) inhibitor, GM6001. Taken together, our results suggest that a ligand-dependent mechanism involving the activity of MMPs plays a key role in the early, shear stress-induced activation of VEGFR2.

Indexed as

Antibodies, NeutralizingBlotting, WesternCells, CulturedCoronary VesselsEndothelium, VascularHumansMatrix MetalloproteinasesNitric Oxide Synthase Type IIIPhosphorylationVascular Endothelial Growth Factor AVascular Endothelial Growth Factor Receptor-2Antibodies, NeutralizingMatrix MetalloproteinasesNitric Oxide Synthase Type IIIVascular Endothelial Growth Factor AVascular Endothelial Growth Factor Receptor-2

Identifiers

PMID23583373
PMCPMC4074593
OpenAlexW1978580975

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.